Collaboration in outpatient antipsychotic drug treatment: Analysis of potentially influencing factors

Psychiatry Research

Volumn 161, Issue 2, 2008, Pages 225-234

  Klingberg, Stefan ^a   Schneider, Sabine ^a   Wittorf, Andreas ^a   Buchkremer, Gerhard ^a   Wiedemann, Georg ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Antipsychotic treatment; Health beliefs; Medication adherence; Medication compliance; Patient collaboration; Schizoaffective disorder; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DRUG USE; FEMALE; HEALTH BEHAVIOR; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOTHERAPY; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; TREATMENT PLANNING;

ADULT; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; AWARENESS; COOPERATIVE BEHAVIOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; PATIENT DISCHARGE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA, PARANOID; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ENVIRONMENT;

EID: 54049117921     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.07.027     Document Type: Article

References (45)

1. Adams J., and Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatrica Scandinavica 101 (2000) 119-124
2. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia, second edition. American Journal of Psychiatry 161 (2004) (Suppl.)
3. Becker M.H., and Maimon L.A. Sociobehavioral determinants of compliance with health and medical care recommendations. Medical Care 13 (1975) 10-24
4. Budd R.J., Hughes I.C.T., and Smith J.A. Health beliefs and compliance with anti-psychotic medication. British Journal of Clinical Psychology 35 (1996) 393-397
5. Byerly M., Fisher R., Whatley K., Holland R., Varghese F., Carmody T., Magouirk B., and Rush A.J. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Research 133 (2005) 129-133
6. Chisholm D., Knapp M.R., Knudsen H.C., Amaddeo F., Gaite L., and van Wijngaarden B. Client Socio-Demographic and Service Receipt Inventory - European Version: development of an instrument for international research. EPSILON Study 5. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. British Journal of Psychiatry 174 (2000) 28-33 (suppl.)
7. Coldham E.L., Addington J., and Addington D. Mediation adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica 106 (2002) 286-290
8. Cramer J.A., and Rosenheck R. Enhancing medication compliance for people with serious mental illness. Journal of Nervous and Mental Disorders 187 (1999) 53-55
9. Cuffel B.J., Alford J., Fischer E.P., et al. Awareness of illness in schizophrenia and outpatient treatment adherence. Journal of Nervous and Mental Disorders 184 (1996) 653-659
10. Deusinger I.M. Die Frankfurter Selbstkonzeptskalen (FSKN) [Frankfurt Self-Concept Scales] (1986), Hogrefe, Göttingen
11. DGPPN - Deutsche Gesellschaft fuer Psychiatrie, Psychotherapie und Nervenheilkunde (Ed.); Gaebel, W., Falkai, P. (Redaktion), 2006. Praxisleitlinien in Psychiatrie und Psychotherapie. Band 1: Behandlungsleitlinie Schizophrenie [Practice guidelines in psychiatry and psychotherapy. Vol. 1: Treatment guideline schizophrenia]. Steinkopff, Darmstadt.
12. Dolder C.R., Lacro J.P., Warren K.A., Golshan S., Perkins D.O., and Jeste D.V. Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence. Journal of Clinical Psychopharmacology 24 (2004) 404-409
13. Feldmann, R., Buchkremer, G., Minneker-Hügel, E., Hornung, W.P., 1995. Fragebogen zur Erfassung der Familienatmosphäre (FEF): Einschätzung des emotionalen Angehörigenverhaltens aus der Sicht schizophrener Patienten [Questionnaire for the assessment of the family atmosphere (FEF). The assessment of the emotional behaviour of relatives from the perspective of schizophrenc patients]. Diagnostica 41, 334-348. 65.
14. Fenton W.S., Blyler C.R., and Heinssen R.K. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 23 (1997) 637-651
15. Franke G. Die Symptom-Checkliste von Derogatis - Deutsche Version (SCL-90-R) ([Symptom Check List 90 Items Revised - German version]) (1995), Beltz-Test-Gesellschaft, Göttingen
16. Gilmer T.P., Dolder C.R., Lacro J.P., Folsom D.P., Lindamer L., Garcia P., and Jeste D.V. Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161 (2004) 692-699
17. Guy W. Assessment Manual for Psychopathology, revised edition (1976), Department of Education, Health and Welfare, Washington, DC
18. Kampman O., and Lehtinen K. Compliance in psychoses. Acta Psychiatrica Scandinavica 100 (1999) 167-175
19. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13 (1987) 261-276
20. Keith S.J., and Kane J.M. Partial compliance and patient consequences in schizophrenia: our patients can do better. Journal of Clinical Psychiatry 64 (2003) 1308-1315
21. Kemp R., and David A. Psychological predictors of insight and compliance in psychotic patients. British Journal of Psychiatry 169 (1996) 444-450
22. Kemp R., Hayward P., Applewhaite G., Everitt B., and David A. Compliance therapy in psychotic patients: randomised controlled trial. British Medical Journal 312 (1996) 345-349
23. Kemp R., Kirov G., Everitt B., Hayward P., and David A. Randomised controlled trial of compliance therapy. 18-month follow-up. British Journal of Psychiatry 172 (1998) 413-419
24. Klingberg S., Wittorf A., Sickinger S., Buchkremer G., and Wiedemann G. Course of cognitive functioning during the stabilization phase of schizophrenia. Journal of Psychiatric Research 42 (2008) 259-267
25. Kozuki Y., and Schepp K.G. Visual-feedback therapy for antipsychotic medication adherence. International Clinical Psychopharmacology 21 (2006) 57-61
26. Lacro J., Dunn L., Dolder C., et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63 (2002) 892-908
27. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B). 2nd edition ([A Multiple Choice Vocabulary Intelligence Test (MWT-B)]) (1992), Perimed-spitta, Nürnberg
28. Linden M., Godemann F., Gaebel W., Köpcke W., Müller P., Müller-Spahn F., Pietzcker A., and Tegeler J. A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years. Schizophrenia Bulletin 27 (2001) 585-596
29. Linden M., Nather J., and Wilms H.U. Zur Definition, Bedeutung und Messung der Krankheitskonzepte von Patienten. Die Krankheitskonzeptskala (KK-Skala) für schizophrene Patienten ([To the definition, importance and measurement of disease concepts in patients. A disorder concept scale (KK-Scale) for schizophrenic patients]). Fortschritte der Neurologie - Psychiatrie 56 (1988) 35-43
30. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., and Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica. Supplementum 334 (1987) 1-100
31. Ludwig W., Huber D., Schmidt S., Bender W., and Greil W. Assessment of compliance-related attitudes in psychiatry: a comparison of two questionnaires based on the health belief model. Social Psychiatry and Psychiatric Epidemiology 25 (1990) 298-303
32. Malla A., Norman R., Schmitz N., Manchanda R., Bechard-Evans L., Takhar J., and Haricharan R. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychological Medicine 36 (2006) 649-658
33. Mutsatsa S.H., Joyce E.M., Hutton S.B., Webb E., Gibbins H., Paul S., and Barnes T.R.E. Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatrica Scandinavica 108 (2003) 439-446
34. Oliver J.P., Huxley P.J., Priebe S., and Kaiser W. Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Social Psychiatry and Psychiatric Epidemiology 32 (1997) 76-83
35. Perkins D.O. Adherence to antipsychotic medications. Journal of Clinical Psychiatry 60 (1999) 25-30
36. Pinikahana J., Happell B., Taylor M., and Keks N.A. Exploring the complexity of compliance in schizophrenia. Issues in Mental Health Nursing 23 (2002) 513-528
37. Robinson D.G., Woerner M.G., Alvir J.M.J., Bilder R.M., Hinrichsen G.A., and Lieberman J.A. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research 57 (2002) 209-219
38. Sass H., Wittchen H.U., and Zaudig M. Diagnostisches und Statistisches Manual Psychischer Störungen- DSM IV. Übersetzt nach der vierten Auflage des Diagnostic and Statistical Manual of Mental Disorders der American Psychiatric Association (1996), Hogrefe, Göttingen
39. Simpson G., and Angus J. A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica 212 (1970) 11-19
40. Thompson K., Kulkarni J., and Sergejew A. Reliability and validity of the new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research 42 (2000) 241-247
41. Vauth R., Loeschmann C., Ruesch N., and Corrigan P.W. Understanding adherence to neuroleptic treatment in schizophrenia. Psychiatry Research 126 (2004) 43-49
42. Velligan D.I., Lam Y.W., Glahn D.C., Barrett J.A., Maples N.J., Ereshefsky L., and Miller A.L. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophrenia Bulletin 32 (2006) 724-742
43. Weiden P., and Zygmunt A. Medication noncompliance in schizophrenia. I. Assessment. Journal of Practical Psychiatry and Behavioral Health 3 (1997) 106-110
44. Yamada K., Watanabe K., and Nemoto N. Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study. Psychiatry Research 141 (2006) 61-69
45. Young J.L., Zonana H.V., and Shepler L. Medication noncompliance in schizophrenia: codification and update. Bulletin of the American Academy of Psychiatry and the Law 14 (1986) 105-122